158,159 Figure 6 Functional imaging using 17O to map % change i

158,159 Figure 6. Functional imaging using 17O to map % change in cerebral metabolic rate for oxygen (CMR02) vs blood oxygen level-dependent (BOLD) in the cat brain. Adapted rom ref 145: Zhu XH, Zhang N, Zhang Y, Ugurbil K, Chen W. New insights into central roles of cerebral … Conclusion Animal model studies have played a critical role in evaluating the potential of the MR imaging and spectroscopy techniques to study basic brain function, brain diseases,

and mechanisms underlying neuroimaging. Inhibitors,research,lifescience,medical Very high magnetic fields have been indispensable for achieving important gains in biological information content in these studies. The introduction of latest generation of MR systems operating at magnetic fields ranging from ~ 11 to 17 Tesla is expected to advance the field further for animal model experiments. Acknowledgments Acknowledgments: The preparation of this review was in part supported by the National Institute of Neurological Disorders Inhibitors,research,lifescience,medical and Stroke (NINDS) grant R01 NS070815 (GÖ). The Center for MR Research is supported

by National Center for Research Resources (NCRR) biotechnology research resource grant P41 RR008079, National Institute of Biomedical Imaging and Bioengineering (NIBIB) grant P41 EB015894 and NINDS grant P30 NS076408. Selected abbreviations and acronyms MRI magnetic sellectchem resonance imaging BOLD blood oxygen level-dependent CNR contrast to noise ratio MRS magnetic resonance spectroscopy NAA N-acetylaspartate GABA Inhibitors,research,lifescience,medical γ-aminobutyric acid AD Alzheimer’s Inhibitors,research,lifescience,medical disease HD Huntington’s disease
Due to the scarcity of examples of either type of project caricatured above (production or technology), we scrutinize the few that exist for analogies and insights to enhance the best and avoid the worst. inhibitor Idelalisib Lesson one: aggressively encourage technology development from the start. There was not a single Genome Project, but three fundamentally different strategies Inhibitors,research,lifescience,medical and phases—a technology-assessment phase initiated by the Department of Energy (1984-1990),

the NIH-driven production phase (Human Genome Project, HGP, 1990-2004), and the NIH Advanced Sequencing Technology Development (ASTD, 2004-2013) phase. The BRAIN project will hopefully focus on the ASTD precedent, which (with annual funds only 6% of the HGP) helped drop the cost of sequencing by a million-fold in 6 years. It achieved this GSK-3 via advanced imaging and highly multiplexed biochemistry, not mere parallelism via conventional lab robotics. Lesson two: Consider practical applications from the start. It could be said that brain technologies seem less mature than genomics at the corresponding project start points. In reality, no commercial or clinical applications of genomics existed in 1984. In contrast, at the start of the BRAIN project, millions of patients already benefit from cochlear, cardiac, retinal, and deep-brain electrode implant therapies as well as EEG and imaging technologies. Lesson three: The goal need not be “simple.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>